Business Context and Reporting Period
Company: Keros Therapeutics, Inc.
Filing Type: Form 8-K (Current Report)
Date of Report: November 11, 2021
Reporting Period: Event-based report regarding a scheduled conference presentation.
Key Financial Metrics
This filing does not contain financial statements, revenue, profit, cash flow, margin, debt, or liquidity data. The document is a regulatory disclosure regarding a corporate event rather than a financial performance report.
Material Changes
No material financial changes or operational updates were reported in this filing. The sole material event is the announcement of an upcoming investor presentation.
Guidance, Outlook, and Management Commentary
- Upcoming Event: Jasbir Seehra, President and Chief Executive Officer, is scheduled to present at the Jefferies Virtual London Healthcare Conference.
- Event Date: Thursday, November 18, 2021.
- Event Time: 3:00 am ET.
- Disclosure Status: The information is furnished under Regulation FD and is not deemed "filed" for purposes of Section 18 of the Exchange Act.
Investor Verification Checklist
- Verify the content of the press release (Exhibit 99.1) for specific details on the presentation agenda.
- Confirm the presentation schedule and access details for the Jefferies Virtual London Healthcare Conference.
- Note that this filing contains no new financial data; refer to the most recent 10-Q or 10-K for financial metrics.